{"entity":{"type":"insider","cik":"0001657494","url":"/insider/0001657494","json_url":"/insider/0001657494.json","name":"Aurentz Vincent","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2015-12-11","last":"2021-02-18","span_basis":"filed_date"},"name_variants":[{"name":"Aurentz Vincent","source":"filing","n_filings":4,"first_seen":"2019-09-10","last_seen":"2021-02-18"},{"name":"Vincent Aurentz","source":"filing","n_filings":2,"first_seen":"2015-12-11","last_seen":"2015-12-21"}],"transactions":[{"id":4716859,"accession":"0001209191-21-012207","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-012207","line_url":"/filing/0001209191-21-012207#line-3","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001657494","owner_name":"Aurentz Vincent","owner_url":"/insider/0001657494","role":"Officer (Executive VP and CBO)","officer_title":"Executive VP and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2524.0,"shares_display":"2,524","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":214540.0,"total_display":"214,540.00","shares_owned_after":27000.0,"shares_owned_after_display":"27,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":2966152,"accession":"0001209191-20-034544","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-034544","line_url":"/filing/0001209191-20-034544#line-4","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001657494","owner_name":"Aurentz Vincent","owner_url":"/insider/0001657494","role":"Officer (Executive VP and CBO)","officer_title":"Executive VP and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":65.0009,"price_display":"65.00","price_state":"stated","total_value":1625022.5,"total_display":"1,625,022.50","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-04","scope":"insider"},{"id":2529133,"accession":"0001209191-20-007535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-007535","line_url":"/filing/0001209191-20-007535#line-1","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001657494","owner_name":"Aurentz Vincent","owner_url":"/insider/0001657494","role":"Officer (Executive VP and CBO)","officer_title":"Executive VP and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":450000.0,"total_display":"450,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-05","filed_date":"2020-02-07","scope":"insider"},{"id":7884567,"accession":"0001209191-19-049105","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-049105","line_url":"/filing/0001209191-19-049105#line-5","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001657494","owner_name":"Aurentz Vincent","owner_url":"/insider/0001657494","role":"Officer (Executive VP and CBO)","officer_title":"Executive VP and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44672.0,"shares_display":"44,672","price_per_share":50.4835,"price_display":"50.48","price_state":"stated","total_value":2255198.912,"total_display":"2,255,198.91","shares_owned_after":20328.0,"shares_owned_after_display":"20,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider"},{"id":7884562,"accession":"0001209191-19-049105","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049105","line_url":"/filing/0001209191-19-049105#line-4","is_derivative":false,"issuer_cik":"0001080709","issuer_name":"ARENA PHARMACEUTICALS INC","issuer_ticker":"ARNA","issuer_name_source":null,"issuer_url":"/issuer/0001080709","owner_cik":"0001657494","owner_name":"Aurentz Vincent","owner_url":"/insider/0001657494","role":"Officer (Executive VP and CBO)","officer_title":"Executive VP and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20328.0,"shares_display":"20,328","price_per_share":51.2348,"price_display":"51.23","price_state":"stated","total_value":1041501.0144,"total_display":"1,041,501.01","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider"},{"id":8879409,"accession":"0001104659-15-085920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-085920","line_url":"/filing/0001104659-15-085920#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":"0001657494","owner_name":"Vincent Aurentz","owner_url":"/insider/0001657494","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":3.43,"price_display":"3.43","price_state":"stated","total_value":7546.0,"total_display":"7,546.00","shares_owned_after":2200.0,"shares_owned_after_display":"2,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-17","filed_date":"2015-12-21","scope":"insider"},{"id":8690004,"accession":"0001104659-15-084204","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-084204","line_url":"/filing/0001104659-15-084204#line-1","is_derivative":false,"issuer_cik":"0001135906","issuer_name":"EPIRUS Biopharmaceuticals, Inc.","issuer_ticker":"EPRS","issuer_name_source":null,"issuer_url":"/issuer/0001135906","owner_cik":"0001657494","owner_name":"Vincent Aurentz","owner_url":"/insider/0001657494","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2800.0,"shares_display":"2,800","price_per_share":3.85,"price_display":"3.85","price_state":"stated","total_value":10780.0,"total_display":"10,780.00","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001080709","name":"ARENA PHARMACEUTICALS INC","url":"/issuer/0001080709","role":"Officer (Executive VP and CBO)","n_filings":4,"first_seen":"2019-09-10","last_seen":"2021-02-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001135906","name":"EPIRUS Biopharmaceuticals, Inc.","url":"/issuer/0001135906","role":"Officer (Chief Business Officer)","n_filings":2,"first_seen":"2015-12-11","last_seen":"2015-12-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001657494","retrieved_at":"2026-08-22T04:10:18+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}